Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004835 · ClinicalTrials.gov registry record
The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 61
- Enrollment target
NCT01004835: Completed study, sponsored by Scripps Translational Science Institute.
NCT01004835 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01004835 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The objective of this study is to obtain blood or saliva samples to define genes for migraine and pain diseases.
Primary Outcome
By creating a MAPS GeneBank from these patients' blood/saliva donations we will ultimately be able to define genes for migraine and pain diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-05 |
What the finished NCT01004835 record still lists
NCT01004835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01004835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01004835 about?
NCT01004835 is a clinical study titled "The Migraine and Pain Study GeneBank at Scripps Clinic Registry (MAPS)". The objective of this study is to obtain blood or saliva samples to define genes for migraine and pain diseases.
What is the current status of trial NCT01004835?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2009-01. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT01004835?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia